Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID 7070153Search this ID in NIH RePORTER
- ScienceDex PI coverage
- FY2025 through FY2026Career claims are limited to the years shown.
FY2026 award categories
- Pharmacology
NIH Funding · FY2026
Linked Award Amount
$1.8M
Full award amounts, FY2026
Award Records
2
Records listing this PI
Award-Linked Rank
#3,790
By linked amount among FY2026 PIs
Earliest Year Loaded
2025
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2026 award records by amount
NIH award records listing Vincent Collins Ofuka Njar as a PI. Multi-PI records show the full award amount for context.
- 5R44CA291285-02R44Development of VNPP433-3Beta as Novel Therapeutic for All Stages of Prostrate Cancer$1Maward amount
- 1R01CA308805-01A1R01Second-Generation Stat5 Inhibitors for Prostate Cancer Therapy$796.7Kaward amount
Award organizations
Organizations that administered FY2026 awards listing Vincent Collins Ofuka Njar as a PI.
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2025First NIH AwardIsoprene Pharmaceuticals, Inc.
- 2025$500K Cumulative Funding
- 2025$1M Cumulative Funding
- 2025R01 Grant Holder
- 2026$2M Cumulative Funding
- 2026Entered Top 50% NationallyRanked #3790
- 2026Entered Top 25% NationallyRanked #3790
- 2026Multi-Institutional ResearchAwards at 2 institutions
Shared-award investigators
Other investigators listed on at least one of the same NIH award records as Vincent Collins Ofuka Njar.